癌症护理事先授权的患者经验
Fumiko Chino1,2, Alexandra Baez3, Ivy B Elkins4
1Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, New York.
JAMA network open
|October 18, 2023
概括
癌症护理事先授权 (PA) 对22%的患者造成了延迟或拒绝. 该PA过程显著增加了患者的焦虑和对医疗保健系统的不信任.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 患者倡导 患者倡导
背景情况:
- 预先授权 (PA) 是临床医生和患者的一个复杂的过程.
- 延迟和拒绝PA对癌症患者特别有害,需要及时治疗.
研究的目的:
- 为了调查患者对癌症护理的PA的观点.
- 了解患者对PA过程,结果和行政负担的看法.
主要方法:
- 在患有PA的患者中进行了一项横截面的匿名调查.
- 参与者通过社交媒体和癌症倡导组织招募.
主要成果:
- 22%的患者由于PA延迟或拒绝而没有接受推的癌症治疗.
- 大多数患者经历了延误 (73%>2周),严重的行政负担 (20%的时间>11小时),以及增加的焦虑.
- 对保险公司和医疗保健系统的信任产生了负面影响.
结论:
- 在癌症患者中,PA 过程会产生显著的不良结果.
- 与PA相关的延迟和行政负担增加了患者的焦虑和不信任.
- 这些发现凸显了在瘤学中改善PA过程的必要性.
相关概念视频
Nursing Ethical Principles II
993
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
993
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Patient-centered Care
2.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


